Comprehensive atrial functions among CAD patients, and investigated the association between atrial deformation and the severity of CAD or the distribution pattern of involved coronary artery, by using VVI. Our study showed a high feasibility. CAD patients were found with decreased SRe of LA as well as increased ea, SRa and ea/es ratio of RA. Patients with purchase Tubastatin-A exclusively LAD stenosis were found with significantly enhanced SRa and ea/es ratio of LA, while patients with exclusively LCX/ RCA stenosis were not. LA function measured as volumetric parameters by real-time three-dimenstional echocardiography is 22948146 considered a robust marker of LV filling pressure and an indicator of LV diastolic function [23]. Recent studies have shown that LA myocardial deformation parameters might be reduced before the atrial volume was changed [24,25]. Furthermore, it is recommended to use several, rather than single doppler echocardiographic technique for the accurate assessment 
of cardiac diastolic function [26]. VVI is an emerging and promising angle-independent echocardiographic technique to measure strain by speckles tracking, which overcomes the limitations of tissue doppler MedChemExpress 16960-16-0 imaging [27].Atrial Deformation and Coronary Artery DiseaseTable 3. Velocity vector imaging-based measurements of LA/RA according to the severity of coronary stenosis.Variablecontrol group (n = 25)mild CAD group (n = 20)severe CAD group (n = 40)P Value OverallLA Global maximum volume, cm3 maximal LA volume index, mL/m Peak dv/dt, ml/s es, ea, SRs,s21 SRe,s21 Sra,s21 ea/es ratio LA lateral es, ea, SRs,s21 SRe,s21 SRa,s21 ea/es ratio Septum es, ea, SRs,s21 SRe,s21 SRa,s21 ea/es ratio RA Global maximum volume, cm3 maximal RA volume index, mL/m2 Peak dv/dt, ml/s es, ea, SRs,s21 SRe,s21 SRa,s21 ea/es ratio RA lateral es, ea, SRs,s2162.34619.78 30.41611.73 151.77650.05 32.39610.31 17.9469.99 1.2960.38 21.0860.30 21.1460.38 0.4660.67.11615.46 33.6869.34 148.53641.36 28.6769.71 13.4864.45 1.1560.22 20.8460.45* 21.0760.36 0.5160.65.5622.18 31.41611.21 156.12662.89 28.6968.75 14.5966.06 1.1660.29 20.9360.34* 21.2260.48 0.4960.0.71 0.60 0.87 0.31 0.08 0.19 0.03 0.43 0.33.94610.36 15.2765.92 1.5460.50 21.2160.32 21.0760.41 0.4560.31.5869.24 15.2365.08 1.3060.37 20.8860.49** 21.1760.35 0.5060.29.6867.67 13.2065.72 1.3360.44 21.0160.32* 21.4560.68** 0.4460.0.18 0.25 0.14 0.01 0.02 0.35.06614.00 16.3867.49 1.2360.44 21.0560.36 21.1460.38 0.4760.28.38610.48 14.2566.38 1.2260.37 20.8960.44 21.1460.44 0.5360.32.10611.84 17.3967.89 1.2260.48 20.8860.33 21.3360.59 0.5560.0.17 0.31 0.99 1516647 0.17 0.22 0.61.57620.07 29.97610.26 133.34643.84 39.20614.46 15.2367.54 1.2860.43 20.9460.39 21.0460.46 0.3860.57.04615.66 28.4668.78 116.74643.02 43.78614.74 22.1669.35* 1.2460.51 20.7460.35 21.2960.49 0.5260.**52.46616.43 25.1067.87 117.65652.02 39.49614.74 19.3669.13* 1.2360.42 20.8660.35 21.3860.52** 0.5260.15**0.12 0.09 0.39 0.50 0.04 0.91 0.21 0.03 0.52.85622.85 21.58612.04 1.6760.71 21.1260.45 21.2860.72 0.4160.**59.69619.89 31.95621.61 1.7160.67 21.0760.51 21.7460.73* 0.5460.*55.66625.55 29.25615.06 1.6360.59 21.0960.44 21.7660.79* 0.5460.13**0.64 0.07 0.89 0.93 0.04 0.SRe,s21 SRa,s21 ea/es ratio*p,0.05 versus control group; p,0.01 versus control group; doi:10.1371/journal.pone.0051204.tp,0.05 versus mild CAD group.Numerous studies have demonstrated that strain/strain rate parameters are sensitive descriptors of regional myocardial deformation function in evaluating myocardial ischemia [9,10,28,29],.Comprehensive atrial functions among CAD patients, and investigated the association between atrial deformation and the severity of CAD or the distribution pattern of involved coronary artery, by using VVI. Our study showed a high feasibility. CAD patients were found with decreased SRe of LA as well as increased ea, SRa and ea/es ratio of RA. Patients with exclusively LAD stenosis were found with significantly enhanced SRa and ea/es ratio of LA, while patients with exclusively LCX/ RCA stenosis were not. LA function measured as volumetric parameters by real-time three-dimenstional echocardiography is 22948146 considered a robust marker of LV filling pressure and an indicator of LV diastolic function [23]. Recent studies have shown that LA myocardial deformation parameters might be reduced before the atrial volume was changed [24,25]. Furthermore, it is recommended to use several, rather than single doppler echocardiographic technique for the accurate assessment of cardiac diastolic function [26]. VVI is an emerging and promising angle-independent echocardiographic technique to measure strain by speckles tracking, which overcomes the limitations of tissue doppler imaging [27].Atrial Deformation and Coronary Artery DiseaseTable 3. Velocity vector imaging-based measurements of LA/RA according to the severity of coronary stenosis.Variablecontrol group (n = 25)mild CAD group (n = 20)severe CAD group (n = 40)P Value OverallLA Global maximum volume, cm3 maximal LA volume index, mL/m Peak dv/dt, ml/s es, ea, SRs,s21 SRe,s21 Sra,s21 ea/es ratio LA lateral es, ea, SRs,s21 SRe,s21 SRa,s21 ea/es ratio Septum es, ea, SRs,s21 SRe,s21 SRa,s21 ea/es ratio RA Global maximum volume, cm3 maximal RA volume index, mL/m2 Peak dv/dt, ml/s es, ea, SRs,s21 SRe,s21 SRa,s21 ea/es ratio RA lateral es, ea, SRs,s2162.34619.78 30.41611.73 151.77650.05 32.39610.31 17.9469.99 1.2960.38 21.0860.30 21.1460.38 0.4660.67.11615.46 33.6869.34 148.53641.36 28.6769.71 13.4864.45 1.1560.22 20.8460.45* 21.0760.36 0.5160.65.5622.18 31.41611.21 156.12662.89 28.6968.75 14.5966.06 1.1660.29 20.9360.34* 21.2260.48 0.4960.0.71 0.60 0.87 0.31 0.08 0.19 0.03 0.43 0.33.94610.36 15.2765.92 1.5460.50 21.2160.32 21.0760.41 0.4560.31.5869.24 15.2365.08 1.3060.37 20.8860.49** 21.1760.35 0.5060.29.6867.67 13.2065.72 1.3360.44 21.0160.32* 21.4560.68** 0.4460.0.18 0.25 0.14 0.01 0.02 0.35.06614.00 16.3867.49 1.2360.44 21.0560.36 21.1460.38 0.4760.28.38610.48 14.2566.38 1.2260.37 20.8960.44 21.1460.44 0.5360.32.10611.84 17.3967.89 1.2260.48 20.8860.33 21.3360.59 0.5560.0.17 0.31 0.99 1516647 0.17 0.22 0.61.57620.07 29.97610.26 133.34643.84 39.20614.46 15.2367.54 1.2860.43 20.9460.39 21.0460.46 0.3860.57.04615.66 28.4668.78 116.74643.02 43.78614.74 22.1669.35* 1.2460.51 20.7460.35 21.2960.49 0.5260.**52.46616.43 25.1067.87 117.65652.02 39.49614.74 19.3669.13* 1.2360.42 20.8660.35 21.3860.52** 0.5260.15**0.12 0.09 0.39 0.50 0.04 0.91 0.21 0.03 0.52.85622.85 21.58612.04 1.6760.71 21.1260.45 21.2860.72 0.4160.**59.69619.89 31.95621.61 1.7160.67 21.0760.51 21.7460.73* 0.5460.*55.66625.55 29.25615.06 1.6360.59 21.0960.44 21.7660.79* 0.5460.13**0.64 0.07 0.89 0.93 0.04 0.SRe,s21 SRa,s21 ea/es ratio*p,0.05 versus control group; p,0.01 versus control group; doi:10.1371/journal.pone.0051204.tp,0.05 versus mild CAD group.Numerous studies have demonstrated that strain/strain rate parameters are sensitive descriptors of regional myocardial deformation function in evaluating myocardial ischemia [9,10,28,29],.
